Diabetes

As we enter Diabetes Month, this article looks at ways to foster preparedness and sustainable practices in the face of climate change.

Study compares the risk of developing nonexudative AMD and its progression to exudative AMD in patients with obesity taking GLP-1RAs vs other weight-loss drugs.

Despite the hype surrounding GLP-1 receptor agonists, a significant proportion of patients discontinue treatment after a few months, reducing the chances of long-term benefits.

Study participants who were treated with the GLP-1 inhibitor had a lower risk of dementia, ischemic stroke and all-cause mortality.

Answers to common questions about insulin pump therapy.

Any support you can provide to your sight-impaired patients can help keep them self-sufficient in their diabetes management.

Get the info you need on these new drugs, part of our drug news roundup for September.

Obesity Canada has updated its recommendations on pharmacotherapy for obesity management in adults. Have you kept up? Find out here!